UPDATE 1-GSK boss to address China scandal at results -sources
July 21, 2013 at 14:20 PM EDT
LONDON, July 21 (Reuters) - GlaxoSmithKline Chief Executive Andrew Witty will detail what action the drugmaker is taking in response to allegations of bribery against it in China when he presents quarterly results on Wednesday, sources familiar with the matter said.